Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

International Collaboration of Incident HIV and HCV in Injecting Cohorts (InC3)

ABSTRACT: International Collaboration of Incident HIV and HCV in Injecting Cohorts (InC3)

PROVIDER: PRJNA684642 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

International Collaboration of Incident HIV and HCV in Injecting Cohorts (InC3)

Project description:International Collaboration of Incident HIV and HCV in Injecting Cohorts (InC3)

| PRJNA684643 | ENA

Cohort profile: the international collaboration of incident HIV and hepatitis C in injecting cohorts (InC3) study.

Project description:The International Collaboration of Incident HIV and Hepatitis C in Injecting Cohorts (InC(3)) Study is an international multi-cohort project of pooled biological and behavioural data from nine prospective cohorts of people who inject drugs (PWID). InC(3) brings together researchers from Australia, Canada, USA and the Netherlands with expertise in epidemiology, biostatistics, clinical and behavioural sciences, virology and immunology to investigate research questions relevant to hepatitis C virus (HCV) and HIV outcomes. InC(3) was established to: (i) create a merged multi-cohort study of pooled data from well-characterized cohorts of PWID with prospective data on HIV and HCV infections, with a particular focus on HCV; (ii) facilitate new studies not possible within individual cohorts; and (iii) bring together researchers across disciplines to answer a broad range of research questions. Study cohorts identify acute HCV cases through follow-up of high-risk HCV antibody-negative PWID or through clinical referral networks. To date, data from 1986 to 2010 have been received from all contributing cohorts, with 821 HCV-infected and 1216 HCV-uninfected participants (overall, n = 2037). Data collected include demographics, host genetics, HCV ribonucleic acid testing, alanine aminotransferase testing, HIV/hepatitis B virus testing, HCV therapy, loss to follow-up and mortality. Potential collaborators should contact the InC(3) PI Dr Kimberley Page (kPage@psg.ucsf.edu) for further information.

| S-EPMC3887561 | biostudies-literature

The International Cancer Genome project: Pan-Cancer Analysis of Whole Genomes (PCAWG)

Project description:The Pan-Cancer Analysis of Whole Genomes (PCAWG) study is an international collaboration to identify common patterns of mutation in more than 2,800 cancer whole genomes from the International Cancer Genome Consortium. Building upon previous work which examined cancer coding regions, this project is exploring the nature and consequences of somatic and germline variations in both coding and non-coding regions, with specific emphasis on cis-regulatory sites, non-coding RNAs, and large-scale structural alterations. Read more on the <a href=\"https://dcc.icgc.org/pcawg\" target=\"_blank\">project website</a>.<br>This is a subset featuring RNA-seq transcription profiling data of 27 cancer subtypes in 19 tissues. Some donors have matched normal tissue. As general reference, a subset of normal tissue samples from the GTEx project were included in this experiment.

2020-02-05 | E-MTAB-5200 | biostudies-arrayexpress

Longitudinal changes in DNA methylation associated with clozapine use in treatment-resistant schizophrenia from two international cohorts

Project description:126 Peripheral whole blood samples from 26 individuals across two independent cohorts were collected prior to clozapine initiation, 4-12 weeks after initiation, and a 6 months after initiation.

2024-07-17 | GSE237561 | GEO

The International Cancer Genome project: Pan-Cancer Analysis of Whole Genomes (PCAWG)- Alternative view by individual

Project description:The Pan-Cancer Analysis of Whole Genomes (PCAWG) study is an international collaboration to identify common patterns of mutation in more than 2,800 cancer whole genomes from the International Cancer Genome Consortium. Building upon previous work which examined cancer coding regions, this project is exploring the nature and consequences of somatic and germline variations in both coding and non-coding regions, with specific emphasis on cis-regulatory sites, non-coding RNAs, and large-scale structural alterations. Read more on the <a href=\"https://dcc.icgc.org/pcawg\" target=\"_blank\">project website</a>.<br>This is a subset featuring RNA-seq transcription profiling data of 27 cancer subtypes in 19 tissues. Some donors have matched normal tissue.<br>This is the alternative view of the experiment for Expression Atlas to show gene expression per donor.

2020-02-05 | E-MTAB-5423 | biostudies-arrayexpress

HIV/HCV co-infection proteomics

Project description:Hepatic complications of HCV infection, including fibrosis and cirrhosis are accelerated in HIV-infected individuals. Although liver biopsy remains the gold standard for staging HCV-associated liver disease, this test can result in serious complications and is subject to sampling error. These challenges have prompted a search for non-invasive methods for liver fibrosis staging. To this end, we compared serum proteome profiles at different stages of fibrosis in HIV/HCV co- and HCV mono-infected patients using SELDI-TOF MS.

2018-04-09 | PXD009007 | Pride

ARRA Autism Sequencing Collaboration

Project description:ARRA Autism Sequencing Collaboration

| PRJNA74861 | ENA

Cohort Profile: International Collaboration on Hepatitis C Elimination in HIV Cohorts (InCHEHC).

Project description: Not available

| S-EPMC10859136 | biostudies-literature

Longitudinal changes in DNA methylation associated with clozapine use in treatment-resistant schizophrenia from two international cohorts

Project description:Longitudinal changes in DNA methylation associated with clozapine use in treatment-resistant schizophrenia from two international cohorts

| PRJNA995741 | ENA

HCV Study

Project description:HCV Study using NGS

| PRJEB8405 | ENA